Hep C Drug Stocks in the Spotlight

Description:

According to Adam Feuerstein, "Biotech and drug investors with interest in emerging treatments for hepatitis C turn their attention this week to the European Association for the Study of the Liver (EASL) annual meeting, which kicks off Weds. March 30." Read more here.

>>Also: Top-Rated Biotech Stocks

>>Also: 40 Stocks Analysts Are Insanely Bullish About

Most Viewed Portfolios

View All

Articles

4 Bargain Bin Stocks to Pad Your Portfolio in October

10.01.14 | 10:36 AM

BALTIMORE (Stockpickr) -- Where have all the bargains gone? The U.S. stock market has been on fire for the last five years, busting through new all...

4 Stocks Under $10 to Trade for Breakouts

10.01.14 | 08:14 AM

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percenta...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter